Current understandings of the molecular genetics of gestational trophoblastic diseases

Placenta

Volumn 23, Issue 1, 2002, Pages 20-31

  Li, H W ^a   Tsao, S W ^a   Cheung, A N Y ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; GELATINASE A; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; TELOMERASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UVOMORULIN;

APOPTOSIS; CELL ADHESION; CELL DIFFERENTIATION; CELL INVASION; CELL PROLIFERATION; CHORIOCARCINOMA; CHROMOSOME ANALYSIS; GENE ACTIVATION; GENE INACTIVATION; GENOME IMPRINTING; HUMAN; HYDATIDIFORM MOLE; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; MUTATION; ONCOGENE; ONCOGENE C ERB; ONCOGENE C MYC; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TROPHOBLASTIC DISEASE; TROPHOBLASTIC TUMOR; TUMOR SUPPRESSOR GENE; ADULT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MOLECULAR BIOLOGY; PATHOLOGY; PREGNANCY;

ADULT; CHORIOCARCINOMA; CYTOGENETIC ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENOMIC IMPRINTING; HUMANS; HYDATIDIFORM MOLE, INVASIVE; MOLECULAR BIOLOGY; ONCOGENES; PREGNANCY; TELOMERASE; TROPHOBLASTIC TUMOR, PLACENTAL SITE;

EID: 0036365324     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2001.0744     Document Type: Review

References (84)

1. Ahmed MN, Kim K, Haddad B, Berchuck A & Qumsiyeh MB (2000) Comparative genomic hybridization studies in hydatidiform moles and choriocarcinoma: amplification of 7q21-q31 and loss of 8p12-p21 in choriocarcinoma. Cancer Genet Cytogenet, 116, 10-15.
2. Alarcon RM, Rupnow BA, Graeber TG, Knox SJ & Giaccia AJ (1996) Modulation of c-myc activity and apoptosis in vivo. Cancer Res, 56, 4315-4319.
3. Ariel I, Lustig O, Oyer CE, Elkin M, Gonik B, Rachmilewitz J, Biran H, Goshen R, de Groot N & Hochberg A (1994) Relaxation of imprinting in trophoblastic disease. Gynecol Oncol, 53, 212-219.
4. Arima T, Matsuda T, Takagi N & Wake N (1997) Association of IGF2 and H19 imprinting with choriocarcinoma development. Cancer Genet Cytogenet, 93, 39-47.
5. Azuma C, Saji F, Tokugawa Y, Kimura T, Nobunaga T, Takemura M, Kameda T & Tanizawa O (1991) Application of gene amplification by polymerase chain reaction to genetic analysis of molar mitochondrial DNA: the detection of anuclear empty ovum as the cause of complete mole. Gynecol Oncol, 40, 29-33.
6. Bae SN & Kim SJ (1999) Telomerase activity in complete hydatidiform mole. Am J Obstet Gynecol, 180, 328-333.
7. Barton SC, Surani MAH & Norris ML (1984) Role of maternal and paternal genomes in mouse development. Nature, 311, 374-376.
8. Bauer M, Horn LC, Kowalzik J, Mair W & Czerwenka K (1997) c-erbB-2 amplification and expression in gestational trophoblastic disease correlates with DNA content and karyotype. Gen Diagn Pathol, 143, 185-190.
9. Cheung ANY (1995) Gestational trophoblastic disease. In Topics in Pathology for Hong Kong (Eds) Ho FCS & Wu PC, pp. 147-164. Hong Kong: Hong Kong University Press.
10. Cheung ANY, Srivastava G, Pittaluga S, Man TK, Ngan H & Collins RJ (1993) Expression of c-myc and c-fms oncogenes in trophoblastic cells in hydatidiform mole and normal human placenta. J Clin Pathol, 46, 204-207.
11. Cheung ANY, Sit ASY, Chung LP, Ngan HYS, O'Hanlan K, Wong LC & Ma HK (1994a) Detection of heterozygous XY complete hydatidiform mole by chromosome in situ hybridisation. Gynecol Oncol, 55, 386-392.
12. Cheung ANY, Srivastava G, Chung LP, Ngan HYS, Man TK, Liu YT, Chen WZ, Collins RJ, Wong LC & Ma HK (1994b) Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas. J Reprod Med, 39, 223-227.
13. WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression. J Clin Pathol, 51, 159-162.
14. Cheung ANY, Shen DH, Khoo US, Chiu MPM, Tin VP, Chung LP & Ngan HYS (1999a) Immunohistochemical and mutational analysis of p53 tumour suppressor gene in gestational trophoblastic disease-correlation with mdm2, proliferation index and clinicopathological parameters. Int J Gynecol Cancer, 9, 123-130.
15. Cheung ANY, Zhang DK, Liu Y, Ngan HYS, Shen DH & Tsao SW (1999b) Telomerase activity in gestational trophoblastic disease. J Clin Pathol, 52, 588-592.
16. Cheville JC, Robinson A & Benda JA (1996) p53 expression in placentas with hydropic change and hydatidiform moles. Mod Pathol, 9, 392-396.
17. Chilosi M, Piazzola E, Lestani M, Benedetti A, Guasparri I, Granchelli G, Aldovini D, Leonardi E, Pizzolo G, Doglioni C, Menestrina F & Mariuzzi GM (1998) Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest, 78, 269-277.
18. Chiu PM, Ngan HYS, Khoo US, Cheung ANY (in press) Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome-assessment by M30 cytoDeath antibody which recognizes caspase cleavage site within cytokeratin 18. Histopathol.
19. Chun D & Ma HK (1974) Choriocarcinoma in Hong Kong. J R Coll Surg Edin, 19, 69-81.
20. Diebold J, Arnholdt H, Lai MD & Lohrs U (1991) c-myc expression in early human placenta: a critical evaluation of its localization. Virchows Arch, 61, 65-73.
21. Edwards YH, Jeremiah SJ, McMillan SL, Povey S, Fisher RA & Lawler SD (1984) Complete hydatidiform moles combine maternal mitochondria with a paternal nuclear genome. Ann Hum Genet, 48, 119-127.
22. Feinberg AP (1998) Genomic imprinting and cancer. In The Genetic Basis of Human Cancer (Eds) Vogelstein B & Kinzler KW, pp. 95-107. New York.
23. Fisher RA & Lawler SD (1984) Heterozygous complete hydatidiform moles: do they have a worse prognosis than homozygous complete moles. Lancet, 2, 51.
24. Fisher RA & Newlands ES (1998) Gestational trophoblastic disease-molecular and genetic studies. J Reprod Med, 43, 87-97.
25. Fritsche M, Haessler C & Brandner G (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8, 307-318.
26. Fulop V, Colitti CV, Genest D, Berkowitz RS, Yiu GK, Ng SW, Szepesi J & Mok SC (1998a) DOC-2/hDab2, a candidate tumor suppressor gene involved in the development of gestational trophoblastic diseases. Oncogene, 17, 419-424.
27. Fulop V, Mok SC, Genest DR, Gati I, Doszpod J & Berkowitz RS (1998b) p53, p21, Rb and mdm 2 oncoproteins: expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med, 43, 119-127.
28. Fulop V, Mok SC, Genest DR, Szigetvari I, Cseh I & Berkowitz RS (1998c) c-myc, c-erbB-2, c-fms and bcl-2 oncoproteins: expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med, 43, 101-110.
29. Giannoukakis N, Deal C, Paquette J, Goodyer CG & Polychronakos C (1993) Parental genomic imprinting of the human IGF2 gene. Nat Genet, 4, 98-101.
30. Halperin R, Peller S, Sandbank J, Bukovsky I & Schneider D (2000) Expression of the p53 gene and apoptosis in gestational trophoblastic disease. Placenta, 21, 58-62.
31. Jacobs PA, Szulman AE, Funkhouser J, Matsuura JS & Wilson CC (1982) Human triploidy: relationship between parental origin of the additional haploid complement and development of partial hydatidiform mole. Ann Hum Genet, 46, 223-231.
32. Jinno Y, Ikeda Y, Yun K, Maw M, Masuzaki H, Fukuda H, Inuzuka K, Fujishita A, Ohtani Y & Okimoto T (1995) Establishment of functional imprinting of H19 gene in human developing placentae. Nat Genet, 10, 318-324.
33. Kajii T & Ohama K (1977) Androgenetic origin of hydatidiform mole. Nature, 268, 633-634.
34. Kajii T, Kurashige H, Ohama K & Uchino F (1984) XY and XX complete moles: clinical and morphologic correlation. Am J Obstet Gynecol, 150, 57-64.
35. Lawler SD & Fisher RA (1987) Genetic studies in hydatidiform mole with clinical correlations. Placenta, 8, 77-88.
36. Lawler SD, Fisher RA & Dent J (1991) A prospective study of hydatidiform mole. Am J Obstet Gynecol, 164, 1270-1277.
37. Lawler SD, Fisher RA & Pickhall VJ (1982) Genetic studies on hydatidiform moles. I. The origin of partial moles. Cancer Genet Cytogenet, 5, 309-320.
38. Lawler SD, Pickthall VJ, Fisher RA, Povey S, Evans MW & Szulman AE (1979) Genetic studies of complete and partial hydatidiform moles. Lancet, 2(8142), 580.
39. Lee YS (1995) p53 expression in gestational trophoblastic disease. Int J Gynecol Pathol, 14, 119-124.
40. Leibovitch MP, Nguyen VC, Gross MS, Solhonne B, Leibovitch SA & Bernheim A (1991) The human ASM (adult skeletal muscle) gene: expression and chromosomal assignment to 11p15. Biochem Biophys Res Commun, 180, 1241-1250.
41. Levine AJ, Momand J & Finlay CA (0000) The p53 tumor suppressor gene. Nature, 351, 453-456.
42. Levine AJ, Perry ME, Chang A, Silver A, Dittmer D, Wu M & Welsh D (1994) The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer, 69, 409-416.
43. Lipponen PK (1995) Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer. J Pathol, 175, 203-210.
44. Ma HK & Wong LC (1982) Gestational trophoblastic disease in Hong Kong. Semin Oncol, 9, 224-233.
45. Makino S, Sasaki MS & Fukuschima T (1965) Cytological studies of tumours. XLI. Chromosomal instability in human chorionic lesions. Okajimas Folia Anatomica Japonica, 40, 439-465.
46. Marzusch K, Ruck P, Horny HP, Dietl J & Kaiserling E (1995) Expression of the p53 tumour suppressor gene in human placenta: an immunohistochemical study. Placenta, 16, 101-104.
47. Matsuda T, Sasaki M, Kato H, Yamada H, Cohen M, Barrett JC, Oshimura M & Wake N (1997) Human chromosome 7 carries a putative tumor suppressor gene(s) involved in choriocarcinoma. Oncogene, 15, 2773-2781.
48. Mok SC, Wong KK, Chan RK, Lau CC, Tsao SW, Knapp RC & Berkowitz RS (1994) Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol, 52, 247-252.
49. Mom and J & Zambetti GP (1997) Mdm-2: 'big brother' of p53. J Cell Biochem, 64, 343-352.
50. Mom and J, Zambetti GP, Olson DC, George D & Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245.
51. Morton CC, Byers MG, Nakai H, Bell GI & Shows TB (1986) Human genes for insulin-like growth factors I and II and epidermal growth factor are located on 12q22-q24.1, 11p15, and 4q25-q27, respectively. Cytogenet Cell Genet, 41, 245-249.
52. Muller-Hocker J, Obernitz N, Johannes A & Lohrs U (1997) p53 gene product and EGF-receptor are highly expressed in placental site trophoblastic tumor. Hum Pathol, 28, 1302-1305.
53. Mutter GL, Pomponio RJ, Berkowitz RS & Genest DR (1993a) Sex chromosome composition of complete hydatidiform moles: relationship to metastasis. Am J Obstet Gynecol, 168, 1547-1551.
54. Mutter GL, Stewart CL, Chaponot ML & Pomponio RJ (1993b) Oppositely imprinted genes H19 and insulin-like growth factor 2 are coexpressed in human androgenetic trophoblast. Am J Hum Genet, 53, 1096-1102.
55. Nishi H, Yahata N, Ohyashiki K, Isaka K, Shiraishi K, Ohyashiki JH, Toyama K & Takayama M (1998) Comparison of telomerase activity in normal chorionic villi to trophoblastic diseases. Int J Oncol, 12, 81-85.
56. Ostor A (1996) 'God's first cancer and man's first cure': Milestones in gestational trophoblastic disease. ASCP Rev Pathol, 1, 165-178.
57. Park JS, Namkoong SE, Lee HY, Kim SJ, Hong KJ, Kim IS, Kim KU & Shim BS (1992) Expression and amplification of cellular oncogenes in human developing placenta and neoplastic trophoblastic tissue. Asia Oceania J Obstet Gynaecol, 18, 57-64.
58. Park WW (1957) The occurrence of sex chromatin in chorionepitheliomas and hydatidiform moles. J Pathol Bact, 74, 197-206.
59. Rachmilewitz J, Goshen R, Ariel I, Schneider T, de Groot N & Hochberg A (1992) Parental imprinting of the human H19 genes. FESB Lett, 309, 25-28.
60. Roncalli M, Bulfamante G, Viale G, Springall DR, Alfano R, Comi A, Maggioni M & Polak JM (1994) c-myc and tumour suppressor gene product expression in developing and term human trophoblast. Placenta, 15, 399-409.
61. Saji F, Tokugawa Y, Kimura T, Kamiura S, Nobunaga T, Azuma C & Tanizawa O (1989) A new approach using DNA fingerprinting for the determination of androgenesis as a cause of hydatidiform mole. Placenta, 10, 399-405.
62. Sasa H, Umekage T, Namima M, Arimura S, Nakata H, Watanabe Y & Kobayashi M (1997) Expression of Ras GTPase-activating protein (GAP) in human normal chorionic villi and hydatidiform mole. Placenta, 18, 427-431.
63. Sheppard DM, Fisher RA & Lawler SD (1985) Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines. Cancer Genet Cytogenet, 16, 251-259.
64. Sherr CJ, Roussel MF & Rettenmier CW (1988) Colony-stimulating factor-1 receptor (c-fms). J Cell Biochem, 38, 179-187.
65. Shi YF, Xie X, Zhao CL, Ye DF, Lu SM, Hor JJ & Pao CC (1996) Lack of mutation in tumour-suppressor gene p53 in gestational trophoblastic tumours. Br J Cancer, 73, 1216-1219.
66. Shimizu T, Miwa W, Nakamori S, Ishikawa O, Konishi Y & Sekiya T (1996) Absence of a mutation of the p21/WAF1 gene in human lung and pancreatic cancers. Jpn J Cancer Res, 87, 275-278.
67. Stahle-Backdhal M, Inoue M, Zedenius J, Sandstedt B, DeMarco L, Flam F, Silfversward C, Andrade J & Friedman E (1995) Decreased expression of Ras GTPase activating protein in human trophoblastic tumors. Am J Pathol, 146, 1073-1078.
68. Sulzman AE (1984) Syndromes of hydatidiform moles. Partial vs complete. J Reprod Med, 29, 788-791.
69. Surani MAH, Barton SC & Norris ML (1984) Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature, 308, 548-550.
70. Szulman AE & Surti U (1978a) The syndromes of hydatidiform mole. I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol, 131, 665-671.
71. Szulman AE & Surti U (1978b) The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol, 132, 20-27.
72. Tremblay KD, Saam JR, Ingram RS, Tilghman SM & Bartolomei MS (1995) A parent-specific methylation imprint marks the alleles of the mouse H19 gene. Nat Genet, 9, 407-413.
73. Van de Kaa CA, Schijf CP & de Wilde PC (1996) Persistent gestational trophoblastic disease: DNA image cytometry and interphase cytogenetics have limited predictive value. Mod Pathol, 9, 1007-1014.
74. Vassilakos P, Riotton G & Kajii T (1977) Hydatidiform mole: two entities. A morphological and cytogenetic study with some clinical considerations. Am J Obstet Gynecol, 127, 167-170.
75. Vegh GL, Selcuk Tuncer Z, Fulop V, Genest DR, Mok SC & Berkowitz RS (1999) Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta. Gynecol Oncol, 75, 248-253.
76. Wake N, Fujino T & Hoshi S (1987) The propensity to malignancy of dispermic heterozygous moles. Placenta, 8, 319-326.
77. Wake N, Seki T, Fujita H, Okubo H, Sakai K, Okuyama K, Hayashi H, Shiina Y, Sato H & Kuroda M (1984) Malignant potential of homozygous and heterozygous complete moles. Cancer Res, 44, 1226-1230.
78. Wake N, Takagi N & Sasaki M (1978) Androgenesis as a cause of hydatidiform mole. J Natl Cancer Inst, 60, 51-57.
79. Wake N, Tanaka K, Chapman V, Matsui S & Sandberg AA (1981) Chromosomes and cellular origin of choriocarcinoma. Cancer Res, 41, 3137-3143.
80. Walsh C, Miller SJ, Flam F, Fisher RA & Ohlsson R (1995) Paternally derived H19 is differentially expressed in malignant and nonmalignant trophoblast. Cancer Res, 55, 1111-1116.
81. Wong SY, Ngan HYS, Chan CCW & Cheung ANY (1999) Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. Mod Pathol, 12, 1025-1033.
82. Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR & Livingston DM (1995) Interaction between the retinoblastoma protein and the oncoprotein mdm2. Nature, 375, 694-697.
83. Yang YH, Kwak HM, Park TK, Kim CK & Lee YB (1986) Comparative cytogenetic and clinicopathologic studies on gestational trophoblastic neoplasia, especially hydatidiform mole. Yonsei Med J, 27, 250-260.
84. Yasui W, Akama Y & Kuniyasu H (1996) Expression of cyclindependent kinase inhibitor p21WAF1/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity. J Pathol, 180, 122-128.